During this live webinar, we will discuss the current state of gene therapy for retinal diseases. The indications, mechanism of action, and delivery routes for this novel class of therapeutics will be briefly reviewed. The latest efficacy and safety data of leading gene therapy candidates will be presented along with areas of continued exploration. The participant will leave the webinar with an improved understanding of retinal gene therapy and its potential applications. (Level: Intermediate)
Lecturer: Dr. Christina Y. Weng, Ophthalmologist, Baylor College of Medicine, USA